Gilead Sciences

Asia
Pharma

Enhertu successor, ESMO, Gilead—Fierce Pharma Asia

Fierce provides a deep dive into the hunt for the next Enhertu in breast cancer. ESMO 2026 data featured Chinese assets backed by Big Pharma.
Angus Liu Oct 30, 2026 8:45am
Texas Texas gavel gavel Texas law Texas court TX Attorney General Texas AG Ken Paxton

Gilead to pay $45M to resolve kickback allegations in Texas

Oct 23, 2026 10:57am
Gileads Ahorita campaign

Gilead kicks off Latino AIDS Awareness Day with new campaign

Oct 15, 2026 8:00am
Graphic of two hands trying to untangle a thread inside someones head

Gilead rolls out disease-specific wellness tools with Calm app

Oct 5, 2026 11:57am
Daniel ODay
Favicon Fierce Biotech

CEO O’Day tells Fierce how Gilead reached ‘critical mass’

Sep 16, 2026 8:00am
dart board miss failure

Failed Trodelvy first-line NSCLC trial shows better China data

Sep 12, 2026 9:45pm